Anixa Biosciences annual gross margin
2010
2011
2012
2021
2023
2024
Anixa Biosciences Gross Margin Growth & History (ANIX)
Anixa Biosciences's gross margin was 0.00% for fiscal 2024.
View full Anixa Biosciences company overviewAnixa Biosciences annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-10-31 | 0.00% | −23.33 pp |
| 2023 | 2023-10-31 | 23.33% | — |
| 2021 | 2021-10-31 | 24.80% | — |
| 2012 | 2012-10-31 | 99.59% | +2.99 pp |
| 2011 | 2011-10-31 | 96.60% | +7.87 pp |
| 2010 | 2010-10-31 | 88.74% | — |
Anixa Biosciences quarterly gross margin
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2013 | 2013-01-31 | −1,170.75% | −1270.59 pp |
| Q4 2012 | 2012-10-31 | −2,471.43% | −2571.30 pp |
| Q3 2012 | 2012-07-31 | 99.71% | +0.52 pp |
| Q2 2012 | 2012-04-30 | 99.80% | +28.16 pp |
| Q1 2012 | 2012-01-31 | 99.84% | +30.54 pp |
| Q4 2011 | 2011-10-31 | 99.87% | — |
| Q3 2011 | 2011-07-31 | 99.19% | +57.79 pp |
| Q2 2011 | 2011-04-30 | 71.64% | — |
| Q1 2011 | 2011-01-31 | 69.30% | — |
| Q3 2010 | 2010-07-31 | 41.40% | — |
Anixa Biosciences gross margin trends
Between the periods ended 2010-10-31 and 2024-10-31, Anixa Biosciences's gross margin decreased from 88.74% to 0.00%, a change of −88.74 percentage points. The latest reported quarter, Q1 2013, shows −1,170.75%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Anixa Biosciences source filings ↗